Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hainan Wanwei Pharmaceutical is a Chinese pharmaceutical enterprise focused on the development and manufacturing of high-quality chemical drugs and specialized formulations. Established in 2002 and based in the Haikou National High-tech Zone, the company has built a strong reputation in the fields of cardiovascular, anti-infective, and anti-inflammatory therapeutics. Their core expertise lies in advanced drug delivery technologies, particularly liposomal injections and complex small molecule synthesis. The company's manufacturing facilities are GMP-certified, supporting a portfolio of widely used clinical products such as Alprostadil and various cephalosporin antibiotics. Hainan Wanwei continues to expand its presence in the domestic Chinese market through integrated R&D and large-scale production capabilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hainan Wanwei Pharmaceutical.